CRISPR

CRISPR1-rad51c

ID
ZDB-CRISPR-190417-15
Name
CRISPR1-rad51c
Previous Names
None
Target
Sequence
5' - GGCAGCAGCAGACGGCGTAA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
hg64 rad51c
hg65 rad51c
Expression
Gene expression in Wild Types + CRISPR1-rad51c
No data available
Phenotype
Phenotype resulting from CRISPR1-rad51c
No data available
Phenotype of all Fish created by or utilizing CRISPR1-rad51c
Phenotype Fish Conditions Figures
male organism increased amount, abnormal rad51chg64/hg64 standard conditions Fig. S10 from Ramanagoudr-Bhojappa et al., 2018
female organism decreased amount, abnormal rad51chg64/hg64 standard conditions Fig. S10 from Ramanagoudr-Bhojappa et al., 2018
female sex determination decreased occurrence, abnormal rad51chg64/hg64 standard conditions Fig. S10 from Ramanagoudr-Bhojappa et al., 2018
male sex determination increased occurrence, abnormal rad51chg64/hg64 standard conditions Fig. S10 from Ramanagoudr-Bhojappa et al., 2018
male organism increased amount, abnormal rad51chg65/hg65 standard conditions Fig. 5 from Ramanagoudr-Bhojappa et al., 2018
female organism decreased amount, abnormal rad51chg65/hg65 standard conditions Fig. 5 from Ramanagoudr-Bhojappa et al., 2018
female sex determination decreased occurrence, abnormal rad51chg65/hg65 standard conditions Fig. 5 from Ramanagoudr-Bhojappa et al., 2018
male sex determination increased occurrence, abnormal rad51chg65/hg65 standard conditions Fig. 5 from Ramanagoudr-Bhojappa et al., 2018
caudal artery blood coagulation decreased process quality, abnormal rad51chg65/hg65 (NHGRI-1) light damage: caudal artery Fig. 3 from Raman et al., 2021
nucleate erythrocyte decreased amount, abnormal rad51chg65/hg65 (NHGRI-1) standard conditions Fig. 1 from Raman et al., 2021
caudal artery blood coagulation decreased process quality, abnormal rad51chg65/hg65 (NHGRI-1) chemical treatment by environment: diepoxybutane, light damage: caudal artery Fig. 3 from Raman et al., 2021
caudal vein blood coagulation increased process quality, abnormal rad51chg65/hg65 (NHGRI-1) light damage: caudal vein Fig. 3 from Raman et al., 2021
caudal artery blood coagulation decreased process quality, abnormal rad51chg65/hg65 (NHGRI-1) chemical treatment by environment: diepoxybutane, light damage: caudal vein Fig. 3 from Raman et al., 2021
leukocyte decreased amount, abnormal rad51chg65/hg65 (NHGRI-1) standard conditions Fig. 1 from Raman et al., 2021
Citations